Picture

AstraZeneca - ADDC Collaboration

The collaboration allows for ADDC members to have direct access to the AstraZeneca's library of compounds.

This collaboration between ADDC and AstraZeneca is aimed at at facilitating efforts by researchers from academia and institutions towards the discovery of novel compounds with potential pharmaceutical application.
Click here for more information

Highlighted Partnerships

California Institute for Quantitative Biosciences (QB3)

 QB3 isa tri-campus organization at UC Berkeley, UC San Francisco, and UC Santa Cruz.

QB3 is the University of California’s hub for innovation and entrepreneurship in the life sciences. The...

Royal Society of Chemistry

RSC Chemical Biology

Led by Hiroaki Suga (University of Tokyo), RSC Chemical Biology is a gold open access journal, dedicated to publishing exceptionally significant and breakthrough findings of...

CDRD

 Share resources for the discovery of new drugs stemming rom CDRD and IPS.

Creative BioMart


Creative BioMart provides quality recombinant proteins, diagnostic antibodies and antigens, diagnostic enzymes and pharmaceutical enzymes to the research community of biology, clinical research,...

CEO

development of peptide therapeutics to metastatic cancer

Number of Registered Partnerships

49

So Far
Therapeuitic Areas of Expertise
  • Choices
    Percentage
  • Oncology
     
    32.65%
  • Infectious Diseases
     
    16.33%
  • Neurological Disorders
     
    32.65%
  • Immunology
     
    24.49%
  • Metabolic Disorders
     
    22.45%
  • Cardiology
     
    14.29%
  • Pain
     
    8.16%
  • Other
     
    12.24%
  •  
Therapeutic Approaches
  • Choices
    Percentage
  • Small Molecules
     
    77.55%
  • Biologics
     
    40.82%
  • Biomarkers
     
    4.08%
  • Drug Delivery
     
    4.08%
  • Stem Cells
     
    4.08%
  • Vaccines
     
    2.04%
  • Antibodies
     
    10.2%
  • Other
     
    2.04%
  •